As of October 2024, EyeGene has a market cap of $27.80M. This makes EyeGene the world's 28384th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $26.68M | -24.50% |
2023 | $35.34M | -15.71% |
2022 | $41.93M | -73.37% |
2021 | $157.45M | - |